SCHEMBL467532

SCHEMBL467532

[c]1ccccc1-c1nc2ccccc2[nH]1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 12/20 0.62
RAB9A P51151 12/20 0.62
ALDH1A1 P00352 10/20 0.62
KDM4E B2RXH2 9/20 0.62
SMN1; SMN2 Q16637 9/20 0.62
HSD17B10 Q99714 6/20 0.62
PKM P14618 5/20 0.62
TP53 P04637 3/20 0.62
NPSR1 Q6W5P4 3/20 0.62
ABCB11 O95342 1/20 0.62
GAA P10253 2/20 0.55
PKN1 Q16512 1/20 0.50
PKN2 Q16513 1/20 0.50
HPGD P15428 7/20 0.49
MAPT P10636 3/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
ALOX15 P16050 1/20 0.49
TSHR P16473 1/20 0.49
POLB P06746 1/20 0.49
GFER P55789 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15987471 0.79 NPC1 (0.58) NPC1RAB9AALDH1A1KDM4ESMN1; SMN2
SCHEMBL30561047 0.78 NPC1 (1.00) NPC1RAB9AALDH1A1KDM4ESMN1; SMN2
SCHEMBL30634854 0.78 NPC1 (1.00) NPC1RAB9AALDH1A1KDM4ESMN1; SMN2
SCHEMBL172216 0.78 NPC1 (1.00) NPC1RAB9AALDH1A1KDM4ESMN1; SMN2
Water SCHEMBL9817804 0.76 NPC1 (0.95) NPC1RAB9AALDH1A1KDM4ESMN1; SMN2
SCHEMBL82498 0.76 NPC1 (0.58) NPC1RAB9AALDH1A1KDM4ESMN1; SMN2
SCHEMBL15771070 0.75 NPC1 (0.57) NPC1RAB9AALDH1A1KDM4ESMN1; SMN2
SCHEMBL8485230 0.75 NPC1 (0.57) NPC1RAB9AALDH1A1KDM4ESMN1; SMN2
SCHEMBL15987644 0.75 NPC1 (0.56) NPC1RAB9AALDH1A1KDM4ESMN1; SMN2
SCHEMBL3795975 0.73 ALDH1A1 (0.59) NPC1RAB9AALDH1A1KDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 178 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230220161-A1 POLYIMIDE PRECURSOR PREPARED BY USING POLYCYCLIC MONOMER INCLUDING TRIFLUOROMETHYL GROUP AND FLEXIBLE POLYIMIDE OBTAINED BY USING THE SAME KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2023-07-13 US claimed
CN-114361341-A Laminated image pickup device and image pickup module 索尼公司 2022-04-15 CN claimed
CN-107534050-B Image sensor, laminated image pickup device, and image pickup module 索尼公司 2021-12-14 CN claimed
CN-111316459-A Photoelectric conversion element and imaging device 索尼公司 2020-06-19 CN claimed
US-10566548-B2 Image sensor, stacked imaging device and imaging module SONY CORPORATION (JP) 2020-02-18 US claimed
EP-3300114-B1 IMAGING ELEMENT, MULTILAYER IMAGING ELEMENT AND IMAGING DEVICE SONY CORP (JP) 2020-01-08 EP claimed
US-20180114926-A1 IMAGE SENSOR, STACKED IMAGING DEVICE AND IMAGING MODULE SONY CORPORATION (JP) 2018-04-26 US claimed
EP-3300114-A1 IMAGING ELEMENT, MULTILAYER IMAGING ELEMENT AND IMAGING DEVICE Sony Corporation (JP) 2018-03-28 EP claimed
CN-107534050-A image sensor, laminated image pickup device, and image pickup module 索尼公司 2018-01-02 CN claimed
CN-105441067-B Organic electroluminescent material as well as preparation method and application thereof 中节能万润股份有限公司 2017-05-24 CN claimed
US-8501754-B2 Quinazolinamide derivatives MERCK PATENT GMBH (DE) 2013-08-06 US claimed
WO-2012059442-A2 NEUROTRYPSIN INHIBITORS NEUROTUNE AG (CH) 2012-05-10 WO claimed
CN-101875637-A Organic material and application thereof in organic electroluminescence devices BEIJING VISIONOX TECHNOLOGY CO 2010-11-03 CN claimed
US-20100234324-A1 Quinazolinamide derivatives MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2010-09-16 US claimed
EP-2164833-A2 QUINAZOLINAMIDE DERIVATIVES Merck Patent GmbH (DE) 2010-03-24 EP claimed
WO-2009010139-A2 QUINAZOLINAMIDE DERIVATIVES MERCK PATENT GMBH (DE) 2009-01-22 WO claimed
US-5501850-A COSMETICS MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1996-03-26 US claimed
EP-0581955-A1 USE OF BENZIMIDAZOLE DERIVATIVES AS PROTECTIVE LIGHT FILTERS. MERCK PATENT GMBH (DE) 1994-02-09 EP claimed
WO-1993015712-A1 USE OF BENZIMIDAZOLE DERIVATIVES AS PROTECTIVE LIGHT FILTERS MERCK PATENT GMBH (DE) 1993-08-19 WO claimed
EP-0163237-A2 Di- and tri-peptidal renin inhibitors MERCK & CO. INC. (US) 1985-12-04 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100234324-A1 Quinazolinamide derivatives HSP90AB1, HSP90AA1, HSP90AB2P NPC1 1106/4885RAB9A 790/4885ALDH1A1 1776/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.